Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.01 per share
-
Shares outstanding
-
46,239,275
-
Number of holders
-
56
-
Total 13F shares, excl. options
-
13,319,758
-
Shares change
-
-119,110
-
Total reported value, excl. options
-
$110,811,074
-
Value change
-
-$981,981
-
Number of buys
-
13
-
Number of sells
-
26
-
Price
-
$8.32
Institutional Holders of UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) as of Q3 2022
As of 30 Sep 2022 UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) had 70 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 13,319,758 shares of stock of the company.
Largest 10 holders included MENORA MIVTACHIM HOLDINGS LTD., Stonepine Capital Management, LLC, CREDIT SUISSE AG/, Harel Insurance Investments & Financial Services Ltd., GREAT POINT PARTNERS LLC, RTW INVESTMENTS, LP, Migdal Insurance & Financial Holdings Ltd., Wildcat Capital Management, LLC, Clal Insurance Enterprises Holdings Ltd, and MILLENNIUM MANAGEMENT LLC.
This table shows 70 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.